abstract |
The invention is concerned with novel imidazopyrimidine derivatives of formula (I) n n n n n n n n n n wherein R 1 , R 2 and R 8 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used as pharmaceuticals. |